Pharmacogenetic tailoring of irinotecan-based first-line chemotherapy in metastatic colorectal cancer: results of a pilot study. [electronic resource]
Producer: 20110317Description: 359-66 p. digitalISSN:- 1791-7530
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- analogs & derivatives
- Colorectal Neoplasms -- drug therapy
- DNA, Neoplasm -- genetics
- Female
- Fluorouracil -- therapeutic use
- Follow-Up Studies
- Genotype
- Glucuronosyltransferase -- genetics
- Humans
- Leucovorin -- therapeutic use
- Liver Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Lymphatic Metastasis
- Male
- Middle Aged
- Mutation -- genetics
- Neoplasm Staging
- Pharmacogenetics
- Pilot Projects
- Polymerase Chain Reaction
- Survival Rate
- Thymidylate Synthase -- genetics
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.